Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of continuous phenylephrine versus dobutamine on spinal oxygen saturation
2018-003687-31Phase 4Completed
- Sponsor
- Ghent University Hospital
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of phenylephrine and dobutamine in Spinal Vascular Disease (2 arms), sponsored by Ghent University Hospital. Primary endpoint: Spinal oxygen saturation measured by NIRS. Started Dec 2018; status: completed.
02
Drugs
phenylephrinedobutamine
03
Conditions
Spinal Vascular Disease
Beyond the preview
Go deeper on 2018-003687-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003687-31.